Sobi starts rolling application for refractory gout drug SEL-212 in the US, hoping to take on Amgen’s Krystexxa in the market. Skip to main content Monday 23 June 2025 . BlueSky linkedin ...

Episode 8: Frequently asked questions about gout and uncontrolled gout Brian LaMoreaux, MD, MS, answers frequently asked questions, with topics including: how to define uncontrolled gout, how to ...

The GENESIS II Total Knee System has grown to become one of the most trusted total knee systems on the market. Cutting edge instrumentation, such as the user friendly MIS system and the ream-thru ...

Objective To identify and quantify potential risk factors for osteoarthritis (OA) following traumatic knee injury. Design Systematic review and meta-analyses that estimated the odds of OA for ...